Recent Patents on Anti-Cancer Drug Discovery

Papers
(The median citation count of Recent Patents on Anti-Cancer Drug Discovery is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Acknowledgement to Contributors47
Acknowledgement to Reviewers28
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies26
Research Progress on the Anticancer Activity of Plant Polysaccharides24
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy22
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer20
L-Selenomethylselenocysteine Exerts Inhibitory Effects on the Progressionof Esophageal Cancer by Targeting the PI3K/AKT Signaling Pathway19
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration18
Patent Selections16
Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review16
Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review16
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents15
Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer15
Santacruzamate A Compositions, Analogs and Methods of Use: A Patent Evaluation of WO 2014/018913 (A2)15
Protective Assessment of Novel (BNC Formulation) against Brain Tumor15
The Prognostic Role of Interferon Gamma-inducible Protein 30 in ClearCell Renal Cell Carcinoma with Immune Infiltrates14
The Present State and Potential Applications of Artificial Intelligence in Cancer Diagnosis and Treatment14
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment14
Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer13
Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway13
Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer13
Oral Metronomic Chemotherapy in Nasopharyngeal Carcinoma withRadiotherapy Interruptions: A Lesson Learned from the Lockdown Due toCOVID-1913
Vitexin's Role in Colon Cancer Apoptosis: AMPK/mTOR PathwayModulation Explored Through Experimental and ComputationalApproaches11
Regulating Lipid Metabolism via Mitochondrial Dynamics in Tongue Squamous Cell Carcinoma Cancer Stem Cells11
Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma11
USP31 Activates the Wnt/β-catenin Signaling Pathway and Promotes Gastric Cancer Cell Proliferation, Invasion and Migration11
Acknowledgement To Reviewers11
Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment11
Bioinformatics Analysis of Key Genes Associated with Resistance to the Combination of Bevacizumab and Pemetrexed Chemotherapy in Non-small Cell Lung Cancer11
Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study10
Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database10
Meet the Editorial Board Member10
Patent Selections10
The Causal Effects of Cholelithiasis on Acute Pancreatitis and Pancreatic Cancer: A Large Sample Size Mendelian Randomization Analysis10
Prospective Challenges for Patenting and Clinical Trials of Anticancer Compounds from Natural Products: Coherent Review10
Intracholecystic Papillary-tubular Neoplasm (ICPN) of the Gallbladder: A Case Report Focusing on an Unexpected Pathological Finding10
Bourgeoning Cancer Targets10
Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms10
Patent Selections10
Screening of Candidate Inflammatory Markers of Epithelial Cells in Hepatocellular Carcinoma based on Integration Analysis of TCGA/ICGC Databases and Single-cell Sequencing10
SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways9
lncRNA H22954 Inhibits Angiogenesis in Acute Myeloid Leukemia through a PDGFA-dependent Mechanism9
Puerarin: An Anticancer and Anti-Inflammatory Agent9
Construction and Identification of a Human Colorectal Adenoma Epithelial Cell Line by SV40 Large T-antigen Transfection9
Ubiquitination-related Gene UBTD1 Mediates Poor Prognosis of Colorectal Cancer and Affects Colorectal Cancer Cell Proliferation and Ferroptosis9
Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions8
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review8
Circular RNA NF1-419 Inhibits Proliferation and Induces Apoptosis by Regulating Lipid Metabolism in Astroglioma Cells8
The m 6 A Reader IGF2BP2 Promotes Oral Squamous Cell CarcinomaProgression by Maintaining UCA1 Stability8
Application of Nano Drug Delivery System (NDDS) in Cancer Therapy: A Perspective8
Metallodrugs as Anticancer Chemotherapeutics and Diagnostic Agents: A Critical Patent Review (2010-2020)8
Fatty Acid Synthase (FASN): A Patent Review Since 2016-Present7
Exploring the Anticancer Potentials of Polyphenols: A Comprehensive Review of Patents in the Last Five Years7
Patent Selections7
The Synergistic Effect of Ruthenium Complex Δ-Ru1 and Doxorubicin in a Mouse Breast Cancer Model7
Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model7
Advances in the Treatment of Chronic Myeloid Leukemia7
UBE2L3 Suppresses Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression7
Preface7
Aucubin Inhibits Liver Cancer via HMGB1-mediated Inactivation of the PI3K/AKT/mTOR Signaling Pathway7
The FJQR Has Synergistic Effect with Fluoropyrimidine in the Maintenance Treatment for HER-2 Negative Gastric Cancer7
Prognostic and Therapeutic Values of Autophagy-related Genes in Triple-negative Breast Cancer7
Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug 7
Patent Selections6
pH-responsive Sulfated Hyaluronic Acid Nanoparticles Targeting Tumor Cells and CAFs for the Treatment of Breast Cancer6
Investigating the Therapeutic Potential and Molecular Mechanisms ofDaphnetin: A Comprehensive Review6
A Synergistic Combination of Oleanolic Acid and Apatinib to Enhance Antitumor Effect on Liver Cancer Cells and Protect against Hepatic Injury6
Targeting Notch Pathway in Cancer Diagnostics and Therapeutics: An Emerging Approach5
Morusin Suppresses Pancreatic Cancer Cell Proliferation and Migrationby Targeting SLC6A12 to Inhibit NF-κB and β-catenin SignalingPathways5
LMNB1 and LMNB2 as Prognostic Risk Factors in Hepatocellular Carcinoma: Therapeutic Potential of GSK461364 via Downregulation of LMNB1 and LMNB2 Expression5
Exploring the Molecular Mechanisms and Biological Effects of CELF2 in the Development of Gastric Cancer5
Development of a Novel Lipid Metabolism-related Gene Prognostic Signature for Patients with Colorectal Cancer5
Patents on PARP-1 Inhibitors for the Management of Cancer from 2017-20235
Exosome-Derived Cargos in Immune Microenvironment in Esophageal Carcinoma: A Mini-Review5
KRAS Pathways: A Potential Gateway for Cancer Therapeutics and Diagnostics5
Daidzein and Chicory Extract Arrest the Cell Cycle via Inhibition of Cyclin D/CDK4 and Cyclin A/CDK2 Gene Expression in Hepatocellular Carcinoma5
Nano-carriers based Approaches Loaded with Herbal Bioactive Compounds for the Treatment of Cancer: Recent Updates and Future Prospects5
LINC00936/microRNA-221-3p Regulates Tumor Progression in Ovarian Cancer by Interacting with LAMA35
Epigallocatechin Gallate Derivative Y6 Reverses Oxaliplatin Resistance inHepatocellular Carcinoma via Targeting the MiR-338-3p/HIF-1α/TWISTAxis to Inhibit EMT4
Patent Selections4
Identification of Breast Cancer Immune-related Prognostic Characteristics in Tumor Microenvironment4
ZFP36L1 Promotes Gastric Cancer Progression via Regulating JNK and p38 MAPK Signaling Pathways4
Structure-Based Virtual Screening of Novel FOXM1 Inhibitors as Potential Compounds for Glioblastoma Treatment4
Targeting Ferroptosis as a New Approach for Radiation Protection and Mitigation4
Altering Landscape of Cancer Vaccines: Unique Platforms, Research on Therapeutic Applications and Recent Patents4
Ribosome-inactivating Protein MAP30 Isolated from Momordica Charantia L. Induces Apoptosis in Hepatocellular Carcinoma Cells4
TGF-β Score based on Silico Analysis can Robustly Predict Prognosis and Immunological Characteristics in Lower-grade Glioma: The Evidence from Multicenter Studies4
Strategies for Developing Cancer Theranostics Approaches4
Green Synthesized Nanoparticles as a Plausible Therapeutic Strategy Against Hepatocellular Carcinoma: An Update on its Preclinical and Clinical Relevance3
Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin A3
Recent Patents of Pharmaceutical Co-Crystals: Product Development on Anti-Cancer Drugs and Beyond3
Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review3
Competitive Effect of Overexpressed C-terminal of Snail-1 (CSnail) in Control of the Growth and Metastasis of Melanoma Cells3
Antibody-drug Conjugates for Breast Cancer Treatment3
β-estradiol Induces Mitochondrial Apoptosis in Cervical Cancer through the Suppression of AKT/NF-κB Signaling Pathway3
New 1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2H)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other Diseases3
A Single-arm, Open-label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable St3
Patent Selections3
Eukaryotic Initiation Factor 3C Can Affect the Proliferation and Invasion of Ovarian Cancer by Regulating the p53 Signalling Pathway3
Meet the Editorial Board Member3
Patent Selections3
The Impact of Polyphenolics in the Management of Breast Cancer: Mechanistic Aspects and Recent Patents3
Meet the Associate Editorial Board Member3
Adhesin Component Member STAG2 Enhances Cisplatin Tolerance inColorectal Cancer Cells through the Epithelial-mesenchymal TransitionPathway3
Transdermal Drug Delivery: A Step towards Treatment of Cancer2
Unveiling miR-1468-5p: A New Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma2
Dahuang Zhechong Pill Combined with TNS4 Silencing Inhibits theNF-κB/VEGF Pathway To Slow Down The Progression Of PancreaticCancer2
Nanotechnology a Boon for Colorectal Cancer Treatment2
TENT5A Increases Glioma Malignancy and Promotes its Progression2
The Non-hodgkin Lymphoma Treatment and Side Effects: A Systematic Review and Meta-analysis2
Inhibiting the Activity of ABCG2 by KU55933 in Colorectal Cancer2
The Role of KCNMA1 Expression in Digestive Cancers: A Potential Prognostic Biomarker2
1,3,4-Oxadiazoles as Anticancer Agents: A Review2
Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway2
Metal Nanoparticles as Emerging Drug Candidates in the Management of Cancers and Microbial Infectious Diseases2
Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer2
Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Ev2
Updated Progress on Mass Spectrometry Imaging and its Application in Cancer Treatment and Drug Discovery2
Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy2
Increased SLC7A3 Expression Inhibits Tumor Cell Proliferation and Predicts a Favorable Prognosis in Breast Cancer2
Patent Selections2
West African Medicinal Plant Substances and Molecules ActivitiesAgainst Viral Hepatitis B and Hepatocellular Carcinoma2
Preclinical Effects of Melatonin on the Development of Ehrlich's Tumor: A Biochemical, Cognitive, and Molecular Approach2
The Validity of Mobile Applications to Facilitate Patient Care Provided to Cancer Patients: Opportunities and Limitations1
Differential Expression and Distribution of Slco4a1 and Slco1b2 in anInternal Environment Disorder-induced Hepatocellular Carcinoma MouseModel1
Characterization of the Prognosis and Tumor Microenvironment of Cellular Senescence-related Genes through scRNA-seq and Bulk RNA-seq Analysis in GC1
Acknowledgements to Contributor1
Sema3A Affect Osteolytic Bone Metastasis of Non-small Cell Lung Cancer1
Prediction of Cancer Treatment Using Advancements in Machine Learning1
Neochamaejasmine A Promotes Apoptosis and Cell Cycle Arrest in B16F10 Melanoma Cells via JNK and p38 MAPK Signaling Pathway1
The Patent Landscape of BRAF Target and KRAS Target1
Selinexor as a Therapeutic Target: Advances in Non-small Cell and Small Cell Lung Cancer Treatment Strategies1
Identification of Immune Infiltration-related Molecular Features inOvarian Cancer Patients and Experimental Validation of ImmuneResponse Molecular Mechanisms through Integrated WGCNA, MachineLearning,1
Knockdown of RhoA Expression Reverts Enzalutamide Resistance via the p38 MAPK Pathway in Castration-resistant Prostate Cancer1
CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma1
Eudragit, a Nifty Polymer for Anticancer Preparations: A Patent Review1
Withdrawn: Fumarate-1 Mediates the Regulation of Mitochondrial Homeostasis by PGC-1α to Promote Cell Pyroptosis and Inhibit the Thyroid Cancer1
Patent Selections1
Acknowledgements to Reviewer1
LncRNA FAM83H-AS1 Contributes to the Radio-resistance and Proliferation in Liver Cancer through Stability FAM83H Protein1
A Descriptive Review of Cannabis sativa Patents for Cancer Treatment1
From Multiple Myeloma to Acute Myeloid Leukemia: A Case Report of a 61-year-old Woman after 8 Years of Chemotherapy and Immunotherapy1
Advances in Artemisinin-based Therapies: Innovations in Synthesis, Drug Delivery, and Expanding Therapeutic Applications1
The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis1
B-9-8, a Novel Harman Dimer, Reverses ABCG2-mediated Chemotherapeutic Drug Resistance1
The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Previously Treated Advanced Thymic Epithelia Tumors: A Retrospective Analysis1
The Synergistic Anti-tumor Effects of Evodiamine based on Animal Model Experiments: A Systematic Review and Meta-analysis1
Comprehensive Analysis and Experimental Validation of TLL2 as a Potential New Prognostic Biomarker Associated with Immune Infiltration in Lung Adenocarcinoma1
The ER Stress-related Gene Prognostic Signature for PredictingChemosensitivity and Prognosis in AML1
Development and Validation of a Hypoxia-related Prognostic Model for Ovarian Cancer1
PDLIM1 Inhibits Chemoresistance by Blocking DNA Damage Repair in Gastric Cancer1
PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis1
Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials1
A Link Between Chemical Structure and Biological Activity in Triterpenoids1
Roles of TEAD Transcription Factors and their Coactivators in the Progression and Metastasis of Cancers1
Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells1
Diosgenin-loaded Silver Nanoparticles: Dual Protective Role and Enhanced Radiosensitivity against ENU-induced Leukemia and γ-irradiation-inducedLiver Toxicity1
Recent Progress in Natural Anticancer Agents Discovery from Tea (Camellia sinensis): A Review1
Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden1
0.032315015792847